Learn about convertible securities, their types, features, and benefits, and understand conversion processes of bonds and ...

Keel Infrastructure Corp. (NASDAQ/TSX: KEEL), a North American digital and energy infrastructure company (“Keel” or the “Company”), today announced that it intends to offer $350 million aggregate ...

Peabody (NYSE: BTU) today announced the pricing of its offering of $225,000,000 aggregate principal amount of 0.50% ...

Almonty Industries Inc. (“Almonty” or the “Company”) (Nasdaq: ALM) (TSX: AII) (ASX: AII) (Frankfurt: ALI1) today announced the pricing of its oversubscribed offering of US$700,000,000 aggregate ...

Convertible bonds and convertible stocks are a tool that public companies often use for large financings to avoid disturbing their equity cap tables. Warren Buffett’s Berkshire Hathaway has been a big ...

HOUSTON--(BUSINESS WIRE)--PROS Holdings, Inc. (NYSE: PRO) (the “Company”) today announced the pricing of its previously announced private offering of $150.0 million aggregate principal amount of ...

HOUSTON--(BUSINESS WIRE)--CenterPoint Energy, Inc. (NYSE: CNP) or “CenterPoint” today announced the pricing of its offering of $900 million aggregate principal amount of its 3.00% Convertible Senior ...

(i) to pay the cost of the convertible note hedge transactions described below (after such cost is partially offset by the net proceeds to onsemi from the sale of the warrant transactions described ...

Keel Infrastructure Corp. (NASDAQ/TSX: KEEL), a North American digital and energy infrastructure company ('Keel” or the ...

In recent days, Celcuity Inc. completed a US$500 million offering of 0.250% convertible senior notes due August 1, 2032, shortly after releasing detailed Phase 3 VIKTORIA-1 data for its ...

Bitcoin treasury company Strategy announced on Friday that it will repurchase $1.5 billion in 0% convertible notes, due in 2029, retiring about half of the 2029 convertible note tranche’s total ...

Celcuity Inc. (Nasdaq: CELC) ('Celcuity” or the 'Company”), a clinical-stage biotechnology company focused on the development of targeted therapies for the treatment of multiple solid tumor ...